Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Non-Current Liabilities came in at $467.0 million in Q1 2026, down 4.11% year-on-year from $487.0 million in Q1 2025, and down 20.17% quarter-over-quarter from $585.0 million in Q4 2025.
Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $467.0 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $467.0 million, down 4.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $467.0 million (down 4.11% YoY), and the FY2025 annual result was $585.0 million, up 93.71% from the prior year.
- Other Non-Current Liabilities came in at $467.0 million for Q1 2026 at Elanco Animal Health, down from $585.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $638.0 million in Q2 2025 to a low of $225.0 million in Q3 2022.
- The 5-year median for Other Non-Current Liabilities is $432.0 million (2023), against an average of $414.6 million.
- Across the five-year window, Other Non-Current Liabilities declined 26.52% in 2024 and soared 93.71% in 2025, its largest moves.
- Elanco Animal Health's Other Non-Current Liabilities stood at $229.0 million in 2022, then soared by 79.48% to $411.0 million in 2023, then slipped by 26.52% to $302.0 million in 2024, then jumped by 93.71% to $585.0 million in 2025, then declined by 20.17% to $467.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $467.0 million (Q1 2026), $585.0 million (Q4 2025), and $607.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 467.00 Mn |
| Dec 31, 2025 | 585.00 Mn |
| Sep 30, 2025 | 607.00 Mn |
| Jun 30, 2025 | 638.00 Mn |
| Mar 31, 2025 | 487.00 Mn |
| Dec 31, 2024 | 302.00 Mn |
| Sep 30, 2024 | 587.00 Mn |
| Jun 30, 2024 | 465.00 Mn |
| Mar 31, 2024 | 474.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 432.00 Mn |
| Jun 30, 2023 | 411.00 Mn |
| Mar 31, 2023 | 245.00 Mn |
| Dec 31, 2022 | 229.00 Mn |
| Sep 30, 2022 | 225.00 Mn |
| Jun 30, 2022 | 242.00 Mn |
| Mar 31, 2022 | 242.00 Mn |
| Dec 31, 2021 | 262.00 Mn |
| Sep 30, 2021 | 220.00 Mn |
| Jun 30, 2021 | 237.00 Mn |